Astonea Labs

ASTONEALAB

Q: Is the debt of Astonea Labs increasing or decreasing?

The net debt of Astonea Labs is decreasing.Latest net debt of Astonea Labs is ₹38.4 Crs as of Sep-25.This is less than Mar-25 when it was ₹53.19 Crs.

Q: Has the share price of Astonea Labs grown faster than its competition?

There is not enough historical data for the companies share price.

Price

Nano Cap

₹165 Cr.

New to Zerodha? Sign-up for free.

Astonea Labs is a company that focuses on manufacturing and marketing a diverse range of pharmaceutical and cosmetic products. Their offerings include antibiotic drugs, anti-cold medications, antihistamines, diabetes and cardiovascular medications, gynecological products, analgesics, fungal infection treatments, and multivitamins.

Astonea Labs is a company that focuses on manufacturing and marketing a diverse range of pharmaceut… More

Low

118

52W Range

High

185

30.84

Sector PE

29.48

P/B

8.96

Div.Yield

ROE

29.06%

EBIDTA

18.27

ROCE

26.97

EPS

New to Zerodha? Sign-up for free.

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

This data is currently unavailable for this company.

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

ASTONEALAB
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

ASTONEALAB
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

This data is currently unavailable for this company.

Events:

Annual Report

Announcement Date

Dec 27, 2025

Annual Report

Announcement Date

Dec 04, 2025

Annual Report

Announcement Date

Dec 03, 2025

Quarterly Results

Announcement Date

Nov 10, 2025

Quarterly Results

Announcement Date

Jul 11, 2025

More Nano Cap Ideas

See similar 'Nano' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Astonea Labs do?

Astonea Labs specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.

Who are the competitors of Astonea Labs?

Astonea Labs major competitors are Beta Drugs. Market Cap of Astonea Labs is ₹165 Crs. While the median market cap of its peers are ₹1,600 Crs.

Is Astonea Labs financially stable compared to its competitors?

Astonea Labs seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Astonea Labs pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Astonea Labs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Astonea Labs allocated its funds?

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

How strong is Astonea Labs balance sheet?

Balance sheet of Astonea Labs is moderately strong, But short term working capital might become an issue for this company.

Is the profitablity of Astonea Labs improving?

The profit is oscillating. The profit of Astonea Labs is ₹3.55 Crs for TTM, ₹5.35 Crs for Mar 2025 and ₹4.07 Crs for Mar 2024.

Is the debt of Astonea Labs increasing or decreasing?

The net debt of Astonea Labs is decreasing. Latest net debt of Astonea Labs is ₹38.4 Crs as of Sep-25. This is less than Mar-25 when it was ₹53.19 Crs.

Is Astonea Labs stock expensive?

Astonea Labs is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Astonea Labs is 30.84, while 3 year average PE is 33.65. Also latest EV/EBITDA of Astonea Labs is 18.27 while 3yr average is 18.12.

Has the share price of Astonea Labs grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Astonea Labs?

There is Insufficient data to gauge this.

Are mutual funds buying/selling Astonea Labs?

There is Insufficient data to gauge this.

ASTONEALAB

Share Price

Financials

Revenue mix

Shareholdings

Peers

Forensics

Summary

Profit & Loss

Balance sheet

Cashflow

Product wise

Location wise

Recent events

News

Corporate Actions

Events:

Quarterly Results

Quarterly Results

More Nano Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Astonea Labs do?

Who are the competitors of Astonea Labs?

Is Astonea Labs financially stable compared to its competitors?

Does Astonea Labs pay decent dividends?

How has Astonea Labs allocated its funds?

How strong is Astonea Labs balance sheet?

Is the profitablity of Astonea Labs improving?

Is the debt of Astonea Labs increasing or decreasing?

Is Astonea Labs stock expensive?

Has the share price of Astonea Labs grown faster than its competition?

Is the promoter bullish about Astonea Labs?

Are mutual funds buying/selling Astonea Labs?